Streetbeat News

Analyst Ratings

ATAI

JNJ

atai Life Sciences (NASDAQ:ATAI) has shared results from its subsidiary Perception Neuroscience’s Phase 1 study of its proprietary R-ketamine compound PCN-101. The study assessed the safety, tolerability and pharmacokinetic profile of PCN-101 delivered subcutaneously compared to intravenous delivery. Results showed that PCN-101 was generally well-tolerated, and no serious adverse events were reported. The study also showed a favorable safety and tolerability profile compared to Johnson & Johnson's (NYSE:JNJ) Spravato.

Portfolio Pulse from Lara Goldstein

August 09, 2023 | 8:51 pm

ALLK

Allakos (NASDAQ:ALLK) reported Q2 losses of $(0.41) per share, beating the analyst consensus estimate of $(0.48) by 14.58 percent. This represents a 54.44 percent increase over losses of $(0.90) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:51 pm

LLY

A significant amount of unusual options activity has been observed for Eli Lilly (NYSE:LLY), with a majority of investors taking a bearish stance. Whales have been targeting a price range from $200 to $600 for Eli Lilly over the last 3 months. The current price of LLY is up 0.89% at $526.23. Major financial institutions like Morgan Stanley, Citigroup, JP Morgan, Wells Fargo, and Jefferies have maintained positive ratings on Eli Lilly, with price targets ranging from $525 to $615.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 8:46 pm

ANET

Arista Networks (NYSE:ANET) has seen a mix of bullish and bearish trades, with 45% of investors opening trades with bullish expectations and 55% with bearish. Whales have been targeting a price range from $150.0 to $210.0 for Arista Networks over the last 3 months. The stock is currently down -1.66% at $177.46. Wells Fargo, Morgan Stanley, Needham, Keybanc, and Argus Research have maintained their ratings on Arista Networks with price targets ranging from $185 to $225.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 8:46 pm

EQ

Equillium (NASDAQ:EQ) reported Q2 earnings per share of $(0.10), beating the analyst consensus estimate of $(0.21) by 52.38%. This is a 75.61% increase over losses from the same period last year. The company also reported quarterly sales of $9.12 million, beating the analyst consensus estimate of $8.00 million by 14.05%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:41 pm

NATR

Natures Sunshine Products (NASDAQ:NATR) reported Q2 earnings of $0.12 per share, beating the analyst consensus estimate of $0.03 by 300%. The company also reported quarterly sales of $116.55 million, surpassing the analyst consensus estimate of $103.52 million by 12.59%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:39 pm

LIFE

aTyr Pharma reported Q2 losses of $(0.22) per share, beating the analyst consensus estimate of $(0.28) by 21.43 percent. This is a 50 percent increase over losses of $(0.44) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:38 pm

RPAY

Repay Hldgs (NASDAQ:RPAY) reported Q2 earnings of $0.19 per share, missing the analyst consensus estimate of $0.20 by 5%. However, the company's quarterly sales of $71.78 million beat the estimate of $67.50 million by 6.35%. This represents a 11.76% increase in earnings and a 6.45% increase in sales compared to the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 09, 2023 | 8:33 pm

ORCL

A significant investor has taken a bearish stance on Oracle (NYSE:ORCL), with 69% of recent trades being bearish. The whales have been targeting a price range from $97.5 to $170.0 for Oracle over the last 3 months. Piper Sandler has downgraded its action to Overweight with a price target of $130. The current price of ORCL is $113.1, down by 1.85%.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 8:31 pm

QCOM

A whale investor has taken a bullish stance on Qualcomm (NASDAQ:QCOM), with 60% of investors opening trades with bullish expectations and 39% with bearish. The whale has been targeting a price range from $90.0 to $160.0 for Qualcomm over the last 3 months. The current price of QCOM is down -0.93% at $116.57. The next earnings are expected to be released in 84 days.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 8:31 pm